Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

A potentially life-saving cancer treatment is often referred to as the original immunotherapy and it helped pave the way for ...

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster and simpler than current methods.

A new study has shed light on the challenges of converting one type of specialized cell into another, a process critical for ...

September marks Awareness Month, and this year, the INOVA Schar Adult Center hosted a pivotal town meeting to unite advocates ...

BioCentriq has appointed Syed T. Husain as its new chief executive officer (CEO), and as a member of the Board of Directors.

By Andie Bernhardt Click here for updates on this story MILWAUKEE (WDJT) — September is Sickle Cell Awareness Month. Sickle cell is a painful blood disease that’s inherited and affects thousands of ...

The Catholic University of America biology professor Venigalla Rao looks at some of humanity’s great medical challenges — ...

This investor is excited about the transformational potential of one growth stock that he's been eyeing up for his portfolio.